LBO France completed the acquisition of a majority stake in Groupe Hemodia.

Synopsis

LBO France, a private equity firm, completed the acquisition of a majority stake in Groupe Hemodia, a company specialized in the design, production and marketing of single-use medical devices. Financial terms were not disclosed.

Principals

target

Groupe Hemodia

bidder

Lbo France

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

rémi teuliere

CEO at GROUPE HEMODIA

Manager

target

Deal

n/a

Total Value

elena coluccelli guerin

Rothschild & Co

Financial Advisor

target

Deal

n/a

Total Value

gregory fradelizi

Managing Director at Rothschild & Co

Financial Advisor

target

Deals

£ 1.80 B

Total Value

Bidder Team (1)

stéphanie casciola

CEO at LBO FRANCE

Investor

bidder

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy